Latigo Biotherapeutics, Inc. (LTGO)

SEC filing

Latigo Biotherapeutics, Inc.

LTGO · CIK 2056611

4 · Aug 10, 2026 · Tananbaum James B. bought 140K shares at $18.00/share ($2.5M); converted 9.04M shares

Tananbaum James B. bought 140K shares at $18.00/share ($2.5M); converted 9.04M shares

xslF345X06/form4-08102026_080804.xml

xslF345X06/form4-08102026_080804.xmlSEC.gov

Graphics and non-inline formats (not embedded below).